Time to subsequent chemotherapy with capivasertib (capi) plus abiraterone (abi) versus placebo (pbo) plus abi in patients (pts) with PTEN deficient metastatic hormone-sensitive prostate cancer (mHSPC): CAPItello-281


Clarke N., George D. J., De Santis M., Uemura H., Fay A. P., Karadurmus N., ...More

EUROPEAN UROLOGY, vol.89, 2026 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 89
  • Publication Date: 2026
  • Journal Name: EUROPEAN UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Gender Studies Database, MEDLINE, Nature Index
  • Istanbul University-Cerrahpasa Affiliated: No